351
Views
7
CrossRef citations to date
0
Altmetric
Original Article

QSAR studies on pyrazole-4-carboxamide derivatives as Aurora A kinase inhibitorsFootnote

, &

References

  • M.LiA.JungU.GanswindtP.MariniA.FriedlP.T.DanielK.LauberV.JendrossekC.BelkaAurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathwaysBiochem. Pharmcol.792010122129
  • G.MountziosE.TerposM.A.DimopoulosAurora kinases as targets for cancer therapyCancer Treat. Rev.342008175182
  • J.ZhangP.L.YangN.S.GrayTargeting cancer with small molecule kinase inhibitorsNat. Rev. Cancer920092839
  • J.FuM.BianQ.JiangC.ZhangRoles of Aurora kinases in mitosis and tumorigenesisMol. Cancer Res.52007110
  • P.MeraldiR.HondaE.A.NiggAurora kinases link chromosome segregation and cell division to cancer susceptibilityCurr. Opin. Genet. Dev.1420042936
  • H.KatayamaS.SenAurora kinase inhibitors as anticancer moleculesBiochim. Biophys. Acta17992010829839
  • H.KatayamaW.R.BrinkleyS.SenThe Aurora kinases: role in cell transformation and tumorigenesisCancer Metast. Rev.222003451464
  • A.H.KishoreB.M.VedamurthyK.MantelinguS.AgrawalB.A.A.ReddyS.RoyK.S.RangappaT.K.KunduSpecific small-molecule activator of Aurora kinase A induces autophosphorylation in a cell-free systemJ. Med. Chem.512008792797
  • T.E.RawsonM.RüthE.BlackwoodD.BurdickL.CorsonJ.DotsonJ.DrummondC.FieldsG.J.GeorgesB.GollerJ.HalladayT.HunsakerT.KleinheinzH.W.KrellJ.LiJ.LiangA.LimbergA.McNuttJ.MoffatG.PhillipsY.RanB.SafinaM.UltschL.WalkerC.WiesmannB.ZhanA.ZhouB.Y.ZhuP.RügerA.G.CochranA pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailabilityJ. Med. Chem.51200844654475
  • S.HeS.YangG.DengM.LiuH.ZhuW.ZhangS.YanL.QuanJ.BaiN.XuAurora kinase A induces miR-17-92 cluster through regulation of E2F1 transcription factorCell. Mol. Life Sci.67201020692076
  • F.H.JungG.PasquetC.Lambert-van der BremptJ.J.LohmannN.WarinF.RenaudH.GermainC.De SaviN.RobertsT.JohnsonC.DoussonG.B.HillA.A.MortlockN.HeronR.W.WilkinsonS.R.WedgeS.P.HeatonR.OdedraN.J.KeenS.GreenE.BrownK.ThompsonS.BrightwellDiscovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitorsJ. Med. Chem.492006955970
  • D.FancelliJ.MollM.VarasiR.BravoR.ArticoD.BertaS.BindiA.CameronI.CandianiP.CappellaP.CarpinelliW.CrociB.ForteM.L.GiorginiJ.KlapwijkA.MarsiglioE.PesentiM.RocchettiF.RolettoD.SeverinoC.SonciniP.StoriciR.TonaniP.ZugnoniP.Vianello1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profileJ. Med. Chem.49200672477251
  • S.WangC.A.MidgleyF.ScaërouJ.B.GrabarekG.GriffithsW.JacksonG.KontopidisS.J.McClueC.McInnesC.MeadesM.MeznaA.PlaterI.StuartM.P.ThomasG.WoodR.G.ClarkeD.G.BlakeD.I.ZhelevaD.P.LaneR.C.JacksonD.M.GloverP.M.FischerDiscovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitorsJ. Med. Chem.53201043674378
  • R.CraneB.GadeaL.LittlepageH.WuJ.V.RudermanAurora A, meiosis and mitosisBiol. Cell962003215229
  • M.S.CoumarJ.S.LeouP.ShuklaJ.S.WuA.K.DixitW.H.LinC.Y.ChangT.W.LienU.K.TanC.H.ChenJ.T.HsuY.S.ChaoS.Y.WuH.P.HsiehStructure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificityJ. Med. Chem.5220091050
  • M.ZhongM.BuiW.ShenS.BaskaranD.A.AllenR.A.EllingW.M.FlanaganA.D.FungE.J.HananS.O.HarrisS.A.HeumannU.HochS.N.IvyJ.W.JacobsS.LamH.LeeR.S.McDowellJ.D.OslobH.E.PurkeyM.J.RomanowskiJ.A.SilvermanB.T.TangonanP.TavernaW.YangJ.C.YoburnC.H.YuK.M.ZimmermanT.O’BrienW.Lew2-Aminobenzimidazoles as potent Aurora kinase inhibitorsBioorg. Med. Chem. Lett.17200951585161
  • K.J.MoriartyH.K.KoblishT.GarrabrantJ.MaisuriaE.KhalilF.AliI.P.PetrouniaC.S.CryslerA.C.MaroneyD.L.JohnsonR.A.GalemmoJr.The synthesis and SAR of 2-amino-pyrrolo[2,3-d]pyrimidines: a new class of Aurora-A kinase inhibitorsBioorg. Med. Chem. Lett.16200657785783
  • S.HowardV.BerdiniJ.A.BoulstridgeM.G.CarrD.M.CrossJ.CurryL.A.DevineT.R.EarlyL.FazalA.L.GillM.HeathcoteS.MamanJ.E.MatthewsR.L.McMenaminE.F.NavarroM.A.O’BrienM.O’ReillyD.C.ReesM.ReuleD.TisiG.WilliamsM.VinkovićP.G.WyattFragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activityJ. Med. Chem.522009379388
  • H.VarmusThe new era in cancer researchScience312200611621165
  • D.G.KingstonD.J.NewmanTaxoids: cancer-fighting compounds from natureCurr. Opin. Drug Discov. Dev.102007130144
  • C.DitchfieldV.L.JohnsonA.TigheR.EllstonC.HaworthT.JohnsonA.MortlockN.KeenS.S.TaylorAurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochoresJ. Cell Biol.1612003267280
  • H.DuZ.HuA.BazzoliY.ZhangPrediction of inhibitory activity of epidermal growth factor receptor inhibitors using grid search-projection pursuit regression methodPLoS ONE67201122367
  • N.FrimayantiL.V.SanghiranS.M.ZainH.A.WahabN.A.Rahman2D, 3D-QSAR, and pharmacophore studies on thiazolidine-4-carboxylic acid derivatives as neuraminidase inhibitors in H3N2 influenza virusMed. Chem. Res.23201414471453
  • X.LiX.LuM.XingX.H.YangT.T.ZhaoH.B.GongH.L.ZhuSynthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agentsBioorg. Med. Chem. Lett.2211201235893593
  • A.GolbraikhA.TropshaPredictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selectionJ. Comput. Aided Mol. Des.162002357369
  • VLife MDS 3.52008Vlife Sciences Technologies, Pvt. Ltd.Pune, India
  • T.A.HalgrenMerck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94J. Comput. Chem.171996553586
  • R.D.CramerIIIJ.D.BunceD.E.PattersonCross validation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studiesQuant. Struct. Act. Relat.719881825